Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $397.39M.
ENTERPRISE VALUE (EV)
$397.39M
Rezolute, Inc.
Market Cap
$408.01M
Enterprise Value (EV)
$397.39M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Rezolute, Inc. (RZLT) | $408.01M | $397.39M |
| Neurogene Inc. (NGNE)vs › | $407.95M | $303.81M |
| Myriad Genetics, Inc. (MYGN)vs › | $406.13M | $501.43M |
| Shoulder Innovations, Inc. (SI)vs › | $404.81M | $395.20M |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.44M | $328.32M |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.43M | $399.37M |
| Carlsmed, Inc. (CARL)vs › | $404.24M | $379.91M |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $413.71M | $522.92M |
| Senseonics Holdings, Inc. (SENS)vs › | $415.22M | $432.31M |
| MapLight Therapeutics, Inc. (MPLT)vs › | $415.88M | $346.23M |
Market Cap
$408.01M
Total Debt
$0.00
Cash
$10.62M
Enterprise Value
$397.39M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
